Drug Shortages & Llama Antibodies: STAT Report
- Another work week is ending, and many are looking forward to the weekend.
- Moderna CEO Stéphane bancel said the company won't invest in new late-stage vaccine trials due to increasing opposition to immunizations from U.S.
Another work week is ending, and many are looking forward to the weekend. Plans are uncertain for some due to a pending storm.Beyond stocking up on caffeine, the agenda includes reading, watching movies, and a listening party featuring artists like Laufey, Lizzy McAlpine, Hozier, Noah Kahan, and Gracie Abrams.
Moderna CEO Stéphane bancel said the company won’t invest in new late-stage vaccine trials due to increasing opposition to immunizations from U.S. officials, Bloomberg News reports.Bancel’s comments are his most direct yet regarding the challenges vaccine manufacturers face under the Trump governance. he’s among several pharmaceutical executives expressing frustration with the government’s stance on immunizations. U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a known vaccine critic, has narrowed eligibility for Covid vaccines, created confusion about access, and questioned their safety. These actions compound existing difficulties for Moderna, which is already navigating a post-pandemic decline.
